​

Funding Round

Series B - Seismic Therapeutic

Series B - Seismic Therapeutic

Investment Firm

Overview

Seismic Therapeutic is a biotechnology company developing machine-learning technology for immunology drug development.

Announced Date

Dec 04, 2023

Closed on Date

Dec 04, 2023

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Bessemer Venture Partners

Bessemer Venture Partners

Bessemer Venture Partners is a early_stage_venture and late_stage_venture firm.

Participant Investors

10

Investor Name
Participant InvestorGaingels
Participant InvestorLightspeed Venture Partners
Participant InvestorGoogle Ventures
Participant InvestorBessemer Venture Partners
Participant InvestorPolaris Partners

Round Details and Background

Seismic Therapeutic raised $121000000 on 2023-12-04 in Series B

Seismic Therapeutic is a biotechnology company developing machine-learning technology for immunology drug development.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 09, 2022
Series A - Seismic Therapeutic
7-101.0M
Dec 04, 2023
Series B - Seismic Therapeutic
12-121.0M

Recent Activity

There is no recent news or activity for this profile.